About Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome is a rare disease catalogued by Orphanet (ORPHA:1171). It is associated with the ATP1A3 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome trials.
Search ClinicalTrials.gov for "Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome" or filter by Orphanet code ORPHA:1171 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome. Updated daily.